Bicara Therapeutics (BCAX) Insider Trading & Ownership

Bicara Therapeutics logo
$25.62 +0.62 (+2.48%)
Closing price 06/24/2026 03:59 PM Eastern
Extended Trading
$25.64 +0.02 (+0.06%)
As of 06/24/2026 05:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bicara Therapeutics (NASDAQ:BCAX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
13.80%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$8.37M
Get BCAX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bicara Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BCAX Insider Buying and Selling by Quarter

Bicara Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/21/2026Sell9,200$20.42$187,864.00  
5/15/2026Sell12,500$20.29$253,625.00  
4/27/2026Sell5,500$22.88$125,840.00  
4/21/2026Sell9,200$23.00$211,600.00  
4/20/2026Sell15,000$23.61$354,150.00  
4/15/2026Sell12,500$23.01$287,625.00  
3/23/2026Sell9,200$18.52$170,384.00  
3/20/2026Sell1,596$18.95$30,244.20  
3/19/2026Sell6,905$18.78$129,675.90  
3/18/2026Sell6,499$18.84$122,441.16  
Stranded On The Flood Plains of History (Ad)

The petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed U.S. Treasury holdings by 45% from peak, and central banks are swapping dollars for gold at the fastest pace since the Cold War. Porter Stansberry believes Trump is channeling more than $3 trillion toward securing the minerals, chips, and infrastructure that make AI possible - and companies at those chokepoints like Vertiv (up 500%), GE Vernova (up 700%), and Arista Networks (up 750%) are already moving. Porter's new briefing names one asset to buy today plus five stocks positioned at the narrowest chokepoints of what he calls the Silicon Dollar.tc pixel

Read Porter's full briefing and get the ticker names today
3/16/2026Sell12,500$19.66$245,750.00  
3/9/2026Sell36,766$19.17$704,804.22  
3/6/2026Sell3,817$18.75$71,568.75  
3/5/2026Sell1,786$18.74$33,469.64  
3/4/2026Sell2,631$18.73$49,278.63  
3/4/2026Sell16,300$18.52$301,876.00  
3/4/2026Sell2,963$18.25$54,074.75  
3/3/2026Sell200$18.45$3,690.00  
3/3/2026Sell13,555$18.22$246,972.10  
3/3/2026Sell17,392$18.16$315,838.72  
1/22/2026Sell1,882$18.15$34,158.30  
1/22/2026Sell3,828$18.10$69,286.80  
1/15/2026Sell149$18.02$2,684.98  
12/15/2025Sell12,500$18.68$233,500.00  
11/24/2025Sell41,163$18.86$776,334.18  
11/24/2025Sell5,500$18.45$101,475.00  
11/24/2025Sell17,795$18.55$330,097.25  
11/21/2025Sell605$18.15$10,980.75  
11/21/2025Sell12,500$18.05$225,625.00  
10/15/2025Sell13,289$18.84$250,364.76  
10/15/2025Sell12,500$18.16$227,000.00  
10/13/2025Sell11,445$18.92$216,539.40  
10/9/2025Sell22,000$18.45$405,900.00  
10/9/2025Sell6,415$18.23$116,945.45  
10/8/2025Sell5,627$18.21$102,467.67  
10/7/2025Sell18,244$18.22$332,405.68  
10/7/2025Sell10,900$18.06$196,854.00  
10/6/2025Sell6,514$18.17$118,359.38  
10/6/2025Sell39,600$18.06$715,176.00  
(Data available from 1/1/2013 forward)

BCAX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Bicara Therapeutics includes Claire Mazumdar, David Raben, Ivan Hyep, James E Flynn, Ra Capital Management, L.P., and Ryan Cohlhepp. Learn more on insiders at BCAX.

13.80% of Bicara Therapeutics stock is owned by insiders. Learn more on BCAX's insider holdings.

The following insiders have purchased BCAX shares in the last 24 months: James E Flynn ($1,260,000.00), and Ra Capital Management, L.P. ($32,994,000.00).

Insiders have purchased a total of 1,903,000 BCAX shares in the last 24 months for a total of $34,254,000.00 bought.

The following insiders have sold BCAX shares in the last 24 months: Claire Mazumdar ($2,738,870.84), David Raben ($938,781.00), Ivan Hyep ($1,916,309.33), and Ryan Cohlhepp ($2,772,965.50).

Insiders have sold a total of 438,466 Bicara Therapeutics shares in the last 24 months for a total of $8,366,926.67 sold.



This page (NASDAQ:BCAX) was last updated on 6/25/2026 by MarketBeat.com Staff.
From Our Partners